相关实验视频

Updated: Mar 2, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.4K

在密码性中风治疗中增加PFO诊断测试的改善患者结果和改善预算影响:美国医院的视角

John J Volpi1, Giorgia Tiozzo2,3, Jet Neervoort2

  • 1The Houston Methodist Institute for Academic Medicine, Houston, TX, USA.

Journal of medical economics
|February 28, 2026
PubMed
概括

在密码性中风患者中增加专利卵孔 (PFO) 诊断测试可以改善患者的治疗结果和医院的财政状况. 这一策略提高了PFO诊断和关闭率,从而改善了健康状况,增加了医院贡献率.

关键词:
一千一百零一年 一百一十年第113章 这是什么?在1919年,我开始了我的生活.在PFO上,PFO是PFO.查检查 查检查 查检查预算影响模型,预算影响分析,PFO相关的中风.密码性脑中风是什么意思 密码性脑中风

更多相关视频

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence10:52

Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

Published on: December 23, 2022

6.4K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

999

相关概念视频

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
565
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
58